Literature DB >> 19672187

Effects of remifentanil on the spectrum and quantitative parameters of electroencephalogram in propofol anesthesia.

Jukka Kortelainen1, Miika Koskinen, Seppo Mustola, Tapio Seppänen.   

Abstract

BACKGROUND: A high dose of opioids associated with a low dose of propofol has become a popular anesthetic technique. However, the influence of opioids on the electroencephalographic phenomenon related to induction of anesthesia and, thereby, on the quantitative parameters used in the depth-of-anesthesia estimation is not well known.
METHODS: Twenty-seven patients were divided into three groups to receive saline, low-dose remifentanil (7.5 microg x kg x h) or high-dose remifentanil (30 microg x kg x h) during induction of anesthesia with propofol (30 mg . kg . h). Electroencephalogram was recorded from Fz electrode, and its time-frequency properties in the patient groups were analyzed from the induction of anesthesia to the occurrence of burst suppression pattern. The group differences in 14 quantitative spectral parameters used in the depth-of-anesthesia estimation were examined as well.
RESULTS: The time-frequency properties of electroencephalogram were different between groups. The high-frequency (greater than 14 Hz) activity during light anesthesia was decreased in remifentanil groups; whereas, increased activity in extended alpha band (7-14 Hz) and decreased activity in delta band (0.5-4 Hz) was observed during deep anesthesia. This resulted in statistically significant changes in all 14 quantitative parameters.
CONCLUSIONS: The effect of remifentanil on the spectrum and quantitative parameters of electroencephalogram is significant and strongly dependent on the level of anesthesia. Coadministration of opioids therefore challenges the reliability of the spectral properties of electroencephalogram in the depth-of-anesthesia estimation by using a frontal montage. Furthermore, the finding has implications for design of opioid coadministration studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672187     DOI: 10.1097/ALN.0b013e3181af633c

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Increased electroencephalographic gamma activity reveals awakening from isoflurane anaesthesia in rats.

Authors:  J Kortelainen; X Jia; T Seppänen; N Thakor
Journal:  Br J Anaesth       Date:  2012-08-19       Impact factor: 9.166

2.  Evaluation of the brain anaesthesia response monitor during anaesthesia for cardiac surgery: a double-blind, randomised controlled trial using two doses of fentanyl.

Authors:  Mehrnaz Shoushtarian; Desmond P McGlade; Louis J Delacretaz; David T J Liley
Journal:  J Clin Monit Comput       Date:  2015-09-25       Impact factor: 2.502

3.  Comparison of the hemodynamic effects of propofol and ketamine as anesthetic induction agents during high-dose remifentanil administration: a single-center retrospective comparative study.

Authors:  Takuro Sanuki; Gaku Mishima; Shinji Kurata; Toshihiro Watanabe; Kensuke Kiriishi; Mizuki Tachi; Yu Ozaki; Ichiro Okayasu; Mari Kawai; Yuki Matsushita; Keiichiro Miura; Takao Ayuse
Journal:  J Dent Anesth Pain Med       Date:  2015-09-30

4.  Remifentanil Alleviates Propofol-Induced Burst Suppression without Affecting Bispectral Index in Female Patients: A Randomized Controlled Trial.

Authors:  Dahye Jung; Sungwon Yang; Min Soo Lee; Yoonki Lee
Journal:  J Clin Med       Date:  2019-08-08       Impact factor: 4.241

5.  Remifentanil and Nitrous Oxide Anesthesia Produces a Unique Pattern of EEG Activity During Loss and Recovery of Response.

Authors:  Sarah L Eagleman; Caitlin M Drover; David R Drover; Nicholas T Ouellette; M Bruce MacIver
Journal:  Front Hum Neurosci       Date:  2018-05-07       Impact factor: 3.169

6.  Nonlinear dynamics captures brain states at different levels of consciousness in patients anesthetized with propofol.

Authors:  Sarah L Eagleman; Divya Chander; Christina Reynolds; Nicholas T Ouellette; M Bruce MacIver
Journal:  PLoS One       Date:  2019-10-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.